| 24-May-13 03:34AM | Alkermes downgraded by MKM Partners Briefing.com |
| 23-May-13 07:06PM | Reading the fine print turns initial Alkermes share loss into a gain at MarketWatch |
| 06:25PM | Alkermes Earnings Beat Estimates, But Outlook Unclear at Investor's Business Daily |
| 04:30PM | Biogen Submits Plegridy BLA Zacks |
| 04:00PM | Alkermes Corporate Presentation to be Webcast at the Deutsche Bank 38th Annual dbAccess Health Care Conference Business Wire |
| 01:52PM | Alkermes Stock Seesaws After Q4 Beat, Guidance Miss at Investor's Business Daily |
| 01:25PM | Alkermes Reports Earnings for Q4 Zacks |
| 01:20PM | Alkermes' CEO Discusses F4Q13 Results - Earnings Call Transcript at Seeking Alpha |
| 12:44PM | Alkermes posts 4Q profit as royalty payments rise AP |
| 11:49AM | Reading the fine print turns initial Alkermes share loss into a gain at MarketWatch |
| 08:46AM | Alkermes Earnings: Everything You Must Know Now at Wall St. Cheat Sheet |
| 08:00AM | Alkermes plc Earnings Call scheduled for 8:00 am ET today CCBN |
| 07:07AM | Q4 2013 Alkermes plc Earnings Release - Before Market Open CCBN |
| 07:00AM | Alkermes plc Reports Financial Results for Fiscal Year 2013 and Provides Financial Expectations Business Wire |
| 12:06AM | ALKERMES PLC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Off EDGAR Online |
| 22-May-13 03:54PM | Alkermes Earnings Seen Rising, But Sales Uncertain at Investor's Business Daily |
| 03:30PM | Stocks Reverse Early Gains; LinkedIn Gives Up 50-Day Line at Investor's Business Daily |
| 07:00AM | Alkermes Announces Data on ALKS 5461 and ALKS 3831 to Be Presented at 53rd Annual NCDEU Meeting Business Wire |
| 21-May-13 01:50PM | QIAGEN Downgraded to Strong Sell Zacks |
| 09:20AM | Yet Another Acquisition for Bayer Zacks |
| 20-May-13 02:57PM | ALKS July Options Begin Trading at TheStreet |
| 10:09AM | Alkermes Stock Hits New 52-Week High (ALKS) at TheStreet |
| 09:40AM | Biogen's Hemophilia BLA Accepted Zacks |
| 16-May-13 04:00PM | Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013 Business Wire |
| 03:30PM | SGEN's Adcetris under FDA Review Zacks |
| 07:00AM | Alkermes Elects Nancy Wysenski to Board of Directors Business Wire |
| 01:01AM | ALKERMES PLC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 15-May-13 04:50PM | Cempra/Toyama Ink Deal Zacks |
| 02:30PM | Much Awaited Test Launch by Genomic Zacks |
| 02:00PM | Myriad Soars Higher on Celeb Clout Zacks |
| 14-May-13 03:30PM | Isis Gets $3.5M Milestone Payment Zacks |
| 10-May-13 04:58PM | SALT 2013: The 5 Best Ideas of the Year Ahead at TheStreet |
| 02:57PM | 6 Superstars For Your Biotech Portfolio: John McCamant at Seeking Alpha |
| 08-May-13 03:31PM | Alkermes' CEO Presents at Bank of America Merrill Lynch Smid Cap Conference (Transcript) at Seeking Alpha |
| 03-May-13 12:09PM | Learn Which Antibody Companies Show Show a Higher Probability of Success; Antibodies Have a Higher Track Record of M&A and More Predictable Toxicology Profile Wall Street Transcript |
| 01-May-13 04:00PM | Alkermes Corporate Presentation to be Webcast at the Bank of America Merrill Lynch 2013 Smid Cap Conference Business Wire |
| 29-Apr-13 11:00AM | BioMarin Widens Loss, Maintains View Zacks |
| 23-Apr-13 03:06PM | Stocks Pull Back Late Session; Apple, Panera Earnings On Tap at Investor's Business Daily |
| 03:00PM | Illumina Beats on Earnings, Revenue Zacks |
| 22-Apr-13 10:36AM | Health stocks ride potential, momentum to a higher close at MarketWatch |
| 07:14AM | Alkermes downgraded to Neutral from Buy at Lazard Capital theflyonthewall.com |
| 21-Apr-13 05:30AM | 5 of Last Week's Biggest Winners at Motley Fool |
| 20-Apr-13 12:35PM | This Week in Biotech: Part 2 at Motley Fool |
| 09:33AM | Biotech Stocks Get A Turbo Boost From Vertex at Seeking Alpha |
| 06:30AM | 3 Humongous Health-Care Stocks This Week at Motley Fool |
| 19-Apr-13 04:37PM | Health stocks ride potential, momentum to a higher close at MarketWatch +7.09% |
| 02:00PM | Alkermes Stock Hits New 52-Week High (ALKS) at TheStreet |
| 18-Apr-13 05:06PM | Cramer's 6 Stocks in 60 Seconds: LDK ALKS APA BBY UNP HFC (Update 1) at TheStreet |
| 04:50PM | Pipeline Progress at Alkermes Zacks |
| 01:27PM | Nasdaq stocks posting largest percentage increases AP |
| 11:01AM | Cramer's 6 Stocks in 60 Seconds: LDK ALKS APA BBY UNP HFC at TheStreet |
| 10:00AM | On The Fly: Analyst Downgrade Summary at theflyonthewall.com |
| 09:53AM | [video] Cramer's Six in 60: LDK, ALKS, APA, BBY, UNP, HFC at CNBC |
| 08:28AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 08:01AM | 2 Biotechs And A Retailer With Recent Intensive Insider Selling at Seeking Alpha |
| 06:18AM | Alkermes downgraded to Neutral from Buy at Mizuho at theflyonthewall.com |
| 17-Apr-13 10:13PM | Alkermes downgraded by Mizuho Briefing.com +16.09% |
| 06:02PM | Nasdaq stocks posting largest percentage increases AP |
| 05:27PM | Alkermes Leaps On Study Results, May Offer New Entry at Investor's Business Daily |
| 04:27PM | Indexes Notch Sharp Declines; New 52-Week Low For Apple at Investor's Business Daily |
| 03:07PM | These Biotech Investors Are Far From Depressed at Motley Fool |
| 03:06PM | Stocks Hold Near Lows, But Alkermes Soars To New High at Investor's Business Daily |
| 02:33PM | Alkermes Jolts On Positive Depression Drug Results at Investor's Business Daily |
| 01:34PM | Why Alkermes Shares Jumped for Joy at Motley Fool |
| 01:29PM | Nasdaq stocks posting largest percentage increases AP |
| 01:20PM | Alkermes shares surge on positive results for depression disorder drug at MarketWatch |
| 01:03PM | 3 Stocks Advancing The Health Care Sector at TheStreet |
| 12:46PM | Alkermes rises on depression drug study results AP |
| 12:45PM | On The Fly: Midday Wrap at theflyonthewall.com |
| 10:37AM | Alkermes Gains as Depression Drug Meets Study Goals at Bloomberg |
| 10:26AM | Three Cheers For Alkermes Running A Depression Study In The US of A at TheStreet |
| 10:26AM | Three Cheers for Alkermes Running a Depression Study in the U.S. of A. at TheStreet |
| 10:24AM | Alkermes Stock Gaps Up On Today's Open (ALKS) at TheStreet |
| 07:01AM | InPlay: Alkermes announces 'positive' results from Phase 2 Clinical Study of ALKS 5461 for Major Depressive Disorder Briefing.com |
| 07:00AM | Alkermes Announces Positive Results from Phase 2 Clinical Study of ALKS 5461 for Major Depressive Disorder Business Wire |
| 16-Apr-13 05:10PM | Biotech Alkermes Poised To Swell On Pipeline Wins at Investor's Business Daily |
| 04:55PM | FDA Bans Generics of Purdue's Older OxyContin Painkiller at Bloomberg |
| 15-Apr-13 06:30PM | Pockets of Strength In Top Groups, Few Leaders Basing at Investor's Business Daily |
| 04:51PM | Alkermes Aims At Bipolar, Addiction Markets To Grow at Investor's Business Daily |
| 11-Apr-13 04:40PM | Alkermes Announces Restructuring Plan Zacks |
| 09-Apr-13 10:09AM | Alkermes unit to reduce headcount up to 130 employees under restructuring at theflyonthewall.com |
| 03:01AM | ALKERMES PLC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities EDGAR Online |
| 07-Apr-13 04:01PM | Why Investors Need to Watch Alkermes at Motley Fool |
| 05-Apr-13 12:00PM | Alkermes Still Not Getting Full Credit For Its Pipeline at Seeking Alpha |
| 01-Apr-13 10:03AM | ALKERMES PLC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 28-Mar-13 04:15PM | This Hedge Fund Knows Heathcare, Do You? at Motley Fool |
| 26-Mar-13 10:35AM | Cramer's 6 Stocks in 60 Seconds: EA BTU ALKS SLB PEP SWN at TheStreet |
| 09:54AM | Analysts: Apple Estimates Are Too High and 4 New Opinions Investors Must Know Now at Wall St. Cheat Sheet |
| 09:53AM | [video] Cramer's Six in 60: Electronic Arts, Peabody Energy, and More! at CNBC |
| 04:01AM | Otsuka to Pay Lundbeck $875 Million for Alzheimers Drug at Bloomberg |
| 21-Mar-13 02:19AM | Alkermes: R&D Complementing Royalties at Seeking Alpha |
| 19-Mar-13 04:51PM | Alkermes Larger Than S&P 500 Component Cliffs Natural Resources at Forbes |
| 18-Mar-13 11:53AM | Renal Denervation, Transcatheter Heart Valves and Hypertension: Learn Which Medical Device Companies are Targeting These Segments Wall Street Transcript |
| 11-Mar-13 05:40PM | Biotech Watch-List: Medicine Co., Alkermes, Celgene at Investor's Business Daily |
| 01-Mar-13 11:53AM | Otsuka, Lundbeck Win Approval for Monthly Abilify Shot at Bloomberg |
| 04:08AM | Otsuka, Lundbeck Win Approval for Monthly Abilify Shot at Bloomberg |
| 28-Feb-13 06:34PM | Otsuka, Lundbeck Win Approval for Monthly Abilify Shot at Bloomberg |
| 12:41PM | Whoa! What Just Happened to My Stock? at Motley Fool |
| 11:18AM | [video] Alkermes: A Biotech With Multiple Drivers at TheStreet |
| 11:18AM | [video] Alkeremes: A Biotech With Multiple Drivers at TheStreet |
